However, during our study period from 2009 to 2012, SGLT-2 inhibitor was not released and the use of GLP-RA was almost insignificant in Korea [ 53 ], therefore we could not evaluate the effects of these drugs on HF and CV mortality.
← all excerpts
The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study.
1
—
—